Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19
Francisco J. Pasquel, Jordan Messler, Robby Booth, Beata Kubacka, April Mumpower, Guillermo E. Umpierrez, Joseph Aloi
Abstract
mortality in the COVID-19-positive population is unknown. Contributing factors could include obesity and a more severe stress state (as suggested by higher insulin requirements). These findings are worrisome and warrant further investigation.
Topics & Concepts
Diabetic ketoacidosisCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakDiabetes mellitusKetoacidosisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineIntensive care medicinePediatricsEmergency medicineVirologyType 1 diabetesDiseaseEndocrinologyInfectious disease (medical specialty)OutbreakDiabetes and associated disordersCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19